Gilead’s Virus Drug Seen in Short Supply for Americans

(Bloomberg) -- The U.S. will get less than half of Gilead Sciences Inc.’s worldwide donation of 1.5 million vials of its Covid-19 medicine over the next six weeks, which isn’t expected to be enough...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.